Stay updated on Pembrolizumab Combo in mCRPC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo in mCRPC Clinical Trial page.

Latest updates to the Pembrolizumab Combo in mCRPC Clinical Trial page
- Check4 days agoChange DetectedThe page's revision label was updated to v3.6.6, signaling a minor metadata/patch update to the page without changes to the study details.SummaryDifference0.0%

- Check11 days agoChange DetectedAn NIH grant/contract identifier for 2018 was added to the study's list of identifiers, indicating NIH support for the trial.SummaryDifference0.0%

- Check18 days agoChange DetectedThe Plain Language Summary section has been removed from the Study Details page, eliminating the lay-friendly overview of the trial.SummaryDifference0.0%

- Check25 days agoChange DetectedRevision: v3.6.5 is now shown on the page, replacing Revision: v3.6.4. This marks a minor update to the page content/version of the study record.SummaryDifference0.0%

- Check39 days agoChange DetectedThe page’s revision tag was updated to v3.6.4, replacing the previous v3.6.3, indicating a patch-level update to the page’s documentation.SummaryDifference0.0%

- Check68 days agoChange DetectedRevision v3.6.3 was added and v3.6.0 was removed in the study's documents section, updating the referenced protocol/SAP version for the trial record.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab Combo in mCRPC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in mCRPC Clinical Trial page.